Press release
Antiobesity Market Top Companies Analysis By Size, Market Share, Current Trends, Growth, Opportunity and Industry Overview Report, 2021-2030 | Covid-19 Impact Analysis
Antiobesity Global Market
https://www.thebusinessresearchcompany.com/global-market-reports
‘Antiobesity Global Market Report 2021 – COVID-19 Impact And Recovery’ by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing this, and highlights of the opportunities that companies in the industry can take on. The market research report helps gain a truly global perspective of the antiobesity industry as it covers 60 geographies. Regional and country breakdowns give an analysis of the market in each geography, with information on the size of the market by region and by country.
The countries covered in the global antiobesity market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.
The regions covered in the global antiobesity market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Know What You Need? Directly Purchase The Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3403
The anti-obesity drugs market consists of sales of anti-obesity drugs and related services. This industry includes establishments that produce pharmacological agents that reduce or control being overweight.
The global antiobesity market is expected to grow from $1.46 billion in 2020 to $2.4 billion in 2021 at a compound annual growth rate (CAGR) of 64.4%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $5.42 billion in 2025 at a CAGR of 22.6%.
Request For A Sample Of The Antiobesity Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3403&type=smp
The global antiobesity market is segmented -
1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs
2) By Type: Prescription Drugs (Rx), OTC Drugs
3) By Medication: Monotherapies, Polytherapies
Major players in the market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and Pfizer Inc.
Need More? Read Further On The Antiobesity Market Here:
https://www.thebusinessresearchcompany.com/report/antiobesity-global-market-report
The Table of Contents includes:
1. Executive Summary
2. Anti-obesity Drugs Market Characteristics
3. Anti-obesity Drugs Market Trends And Strategies
4. Impact Of COVID-19 On Anti-obesity Drugs
5. Anti-obesity Drugs Market Size And Growth
.....
28. Anti-obesity Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Anti-obesity Drugs Market
30. Anti-obesity Drugs Market Future Outlook and Potential Analysis
31. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Get a glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antiobesity Market Top Companies Analysis By Size, Market Share, Current Trends, Growth, Opportunity and Industry Overview Report, 2021-2030 | Covid-19 Impact Analysis here
News-ID: 2488981 • Views: …
More Releases from The Business research company
Exponential Growth Projected: RPA and Hyperautomation Market to Reach $30.75 Bil …
The rpa and hyperautomation market size has grown rapidly in recent years. It will grow from $12.24 billion in 2023 to $14.59 billion in 2024 at a compound annual growth rate (CAGR) of 19.2%. The growth in the historic period can be attributed to cost efficiency and productivity, business process optimization, shift to digital transformation, focus on workforce enhancement, early adoption in it operations.
The rpa and hyperautomation market size is…
Recycled Metal Market Surges to $92.18 Billion by 2028, Driven by Construction S …
The recycled metal market size has grown strongly in recent years. It will grow from $69.28 billion in 2023 to $73 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to material specifications, evolving consumer preferences, market acceptance, infrastructure development, demand from end-use industries.
The recycled metal market size is expected to see strong growth in the next few…
Project Portfolio Management Market to Reach $8.56 Billion by 2028, Driven by Hy …
The project portfolio management market size has grown strongly in recent years. It will grow from $5.55 billion in 2023 to $5.99 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to demand for resource optimization, increasing project failures, globalization of businesses, budget constraints, strategic alignments, demand for mobile accessibility.
The project portfolio management market size is expected to…
Positive Material Identification Market Set to Reach $4.27 Billion by 2028, Driv …
The positive material identification market size has grown strongly in recent years. It will grow from $2.88 billion in 2023 to $3.12 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to safety and quality assurance, industrial expansion, metal processing and fabrication, aerospace and defense applications, oil and gas industry growth.
The positive material identification market size is expected…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
